التفاصيل البيبلوغرافية
العنوان: |
The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension. |
المؤلفون: |
Thangaraj, Sai Sindhu, Oxlund, Christina Stolzenburg, Fonseca, Micaella Pereira Da, Svenningsen, Per, Stubbe, Jane, Palarasah, Yaseelan, Ketelhuth, Daniel F.J., Jacobsen, Ib. Abildgaard, Jensen, Boye L. |
المصدر: |
Journal of Hypertension; Jan2022, Vol. 40 Issue 1, p153-162, 10p |
قاعدة البيانات: |
Complementary Index |